| Literature DB >> 28123354 |
D Sifaki-Pistolla1,2, C Lionis1,2, V Georgoulias3,2, P Kyriakidis4, F Koinis3,2, S Aggelaki3, N Tzanakis5,2.
Abstract
BACKGROUND: The Cancer Registry of Crete is a regional population database that collects cancer morbidity/mortality data along with several risk factors. The current study assessed the geographical variation of lung cancer among ever and never smokers in Crete during the last 20 years.Entities:
Year: 2017 PMID: 28123354 PMCID: PMC5248501 DOI: 10.1186/s12971-017-0114-2
Source DB: PubMed Journal: Tob Induc Dis ISSN: 1617-9625 Impact factor: 2.600
Characteristics of lung cancer patients in Crete (1992 to 2013)
| Characteristics | Lung cancer cases |
| |
|---|---|---|---|
|
| % | ||
| Gender | 0.01 | ||
| Males | 4554 | 87.3 | |
| Females | 660 | 12.6 | |
| Age group (at diagnosis) | <0.001 | ||
| 25–44 | 61 | 1.1 | |
| 45–54 | 263 | 4.8 | |
| 55–64 | 1135 | 20.6 | |
| 65–74 | 1935 | 35.2 | |
| 75–84 | 1754 | 31.9 | |
| <85 | 357 | 6.4 | |
| Stage (at diagnosis) | 0.03 | ||
| I | 650 | 11.8 | |
| II | 457 | 8.3 | |
| III | 887 | 16.1 | |
| IV | 2507 | 45.5 | |
| Not known | 1008 | 18.3 | |
| Personal medical history | 0.04 | ||
| No | 2572 | 50.9 | |
| Lung disease (COPD, Chronic Bronchitis, emphysema) | 1728 | 34.2 | |
| Other cancer (excluding lung cancer) | 193 | 3.8 | |
| Not available/reliable | 564 | 11.2 | |
| Family medical history | 0.04 | ||
| No | 760 | 15 | |
| LC | 937 | 18.5 | |
| Lung disease (COPD, Chronic Bronchitisemphysema) | 2485 | 49.1 | |
| Not available/reliable | 875 | 17.3 | |
| Smoking status* | 0.01 | ||
| Never smoker | 925 | 16.8 | |
| Ever smoker | 4132 | 75.1 | |
| Not known | 452 | 8.1 | |
| Alcohol consumption | 0.04 | ||
| No | 1405 | 25.5 | |
| Yes | 1928 | 35.0 | |
| Not known | 2176 | 39.5 | |
*Pooled data: N = 5,057 lung cancer cases with information on smoking status
Fig. 1Age-Adjusted Incidence Rates per smoking category (a) and gender (b) in Crete from 1992 to 2013
Fig. 2Geographical distribution of Age-Adjusted Incidence Rates/100,000/year and smoking proportion in Crete
Fig. 3Geographical distribution of Age-Standardized Mortality Rates/100,000/year and PAFs (%) in Crete
Average YPLL and PAFs (%) between genders and among age groups*
| Characteristics | Average YPLL (years) | PAF (%) | |
|---|---|---|---|
| Never smokers | Ever smokers | ||
| Gender | |||
| Males | 11 | 16 | 89 |
| Females | 9 | 15 | 78 |
| Age group (at year of diagnosis) | |||
| 25–39 | 35 | 40 | 57 |
| 40–54 | 15 | 23 | 88 |
| 55–64 | 7 | 15 | 89 |
| 65–79 | 4 | 7 | 91 |
| > 80 | 0 | 0 | 92 |
*Pooled data: N = 5,057 lung cancer cases with information on smoking status
Cox Proportional Hazards Multivariate Regression Analysis in lung cancer patients in Crete
| Covariates | β coefficient | Hazard ratio | 95% CI |
|
|---|---|---|---|---|
| Males | 0.6 | 1.3 | 1.2–1.4 | 0.01 |
| Age | 0.9 | 2.1 | 1.9–2.3 | 0.01 |
| Stage II | 0.7 | 1.4 | 1.1–1.7 | 0.03 |
| Stage III | 0.7 | 1.4 | 1.2–1.6 | 0.02 |
| Stage IV | 1.6 | 1.9 | 1.8–2.0 | <0.001 |
| Personal medical history | 0.9 | 1.8 | 1.3–2.3 | 0.03 |
| Family medical history | 0.5 | 1.3 | 1.1–1.5 | 0.02 |
| Ever smoker | 1.8 | 1.5 | 1.3–1.7 | 0.01 |
| Alcohol consumption | 0.3 | 1.1 | 0.4–1.8 | 0.8 |
Fig. 4Observed and predicted lung cancer Net-survival among never and ever smokers, in Crete